BioBridgeXAll companies

Agenus Inc

Biotechnology company · Lexington, Massachusetts, United States · Nasdaq: AGEN

Agenus Inc is a biotechnology company headquartered in Lexington, Massachusetts, United States. Its shares trade on Nasdaq under the ticker AGEN. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $1.3 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2019.

www.agenusbio.comProfile compiled from public records. Is this your company? Request a correction or update

Agenus at a glance

Typebiotechnology company
HeadquartersLexington, Massachusetts, United States
Stock listingNasdaq: AGEN
SEC industryBiological Products, (No Diagnostic Substances)
Employees (self-reported, 2016)70
SEC CIK1098972

What does Agenus do?

US government research funding

6 SBIR/STTR small-business research awards from US health agencies, $1.3 million in total (2000 to 2016). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

11 Form D notices; the most recent reported $30 million sold (2019).

Frequently asked questions about Agenus

Where is Agenus headquartered?

Agenus Inc is headquartered in Lexington, Massachusetts, United States.

What does Agenus do?

Agenus Inc is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Agenus a public company?

Yes. Agenus Inc trades on Nasdaq under the ticker AGEN.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-24. Data licences